Search

everythinglearnresearchcommunity

for

Search:↓

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

Somatostatin may help protect hair follicles from immune attacks.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

People with palmoplantar pustulosis, especially with bone issues, have different mouth bacteria compared to healthy people.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

High-resolution imaging is crucial for diagnosing and planning treatments in clinical anatomy and aging.

Injections improve hair growth, density, and thickness in women safely.

Finasteride helps female-pattern hair loss.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.